Dr. Feinberg is the principal investigator of the Regenerative Biomaterials and Therapeutics Group, founded at Carnegie Mellon University in 2010. He earned his BS in Materials Science and Engineering from Cornell University in 1999 with co-op experience at Abiomed, Inc., working on total artificial hearts. This was followed by MS and PhD degrees in Biomedical Engineering from the University of Florida, where his doctoral work focused on engineering cell-material interactions to prevent and enhance adhesion. Dr. Feinberg then moved to Harvard University as a Postdoctoral Fellow working on developing new biomaterials and cardiac tissue engineering strategies for 3-dimensional myocardial regeneration, with a focus on stem cell-based approaches (and two publications in Science). He subsequently joined CMU in the fall of 2010 as an Assistant Professor with joint appointments in Biomedical Engineering and Materials Science and Engineering. Throughout his career Dr. Feinberg has co-authored over 15 peer-reviewed publications and holds 10 US patents and patent applications. As an Assistant Professor, Dr. Feinberg has received the NIH Director’s 2012 New Innovator Award and the 2013 Ladd Research Award from the Carnegie Institute of Technology at CMU.
Adam Feinberg's lab develops materials-based, regenerative strategies with the goal of engineering the self-organization and self-assembly of various cell types into tissue structures and understanding the emergence of higher-order function in neuromuscular and cardiovascular systems. The specific focus is on the interaction of cells and tissues with engineered materials and determining how cells sense, respond and modulate their environment.